Back to
BAKER BROS. ADVISORS LP
RARX6 quarters
Position history for
BAKER BROS. ADVISORS LP's holdings in RA PHARMACEUTICALS INC
As of its Q1 2020 13F, Baker Bros. Advisors held 2,093,839 shares of RARX (Ra Pharmaceuticals), worth $100.5M. Baker Bros. Advisors' 13F filings listed RARX from Q1 2019 to Q1 2020, 5 quarterly filings. RARX was 0.6% of Baker Bros. Advisors' reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$18.4M
Total Shares Change
-823,113
Quarter-by-Quarter History
Other major holders of RARX: RA CAPITAL MANAGEMENT, L.P.